Dynatrace Inc. Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Dynatrace Inc. Common Stock trades at $61.22 (market cap $17.29B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 3.4× Dynatrace Inc. Common Stock's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.36% dividend while Dynatrace Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dynatrace Inc. Common Stock for 0 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| DT | TAK | |
|---|---|---|
Market Cap | $17.29B | $58.16B |
Volume | 5,001,840 | 2,467,530 |
Sector | Technology | Health |
52-Week High | $61.12 | $19.05 |
52-Week Low | $32.36 | $13.23 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $16.34B | $86.04B |
Dividend Yield | — | 3.36% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Dynatrace provides an observability, security, and automation platform for cloud and IT environments. Its platform integrates data such as logs, metrics, and traces to help organizations monitor digital systems.
Read more on DT →Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →